News

Sartorius Forms Joint Research Pact with Matica Bio for Advanced Viral Vector Manufacturing Technology

October 29, 2021

The research collaboration between Sartorius and Matica Biotechnology will aim to optimize PAT technologies, automation software, and single-use platforms for large-scale viral vector production.

Novavax Files for Authorization of its COVID-19 Vaccine in the UK and Australia

October 29, 2021

Novavax has filed its COVID-19 vaccine for authorization in the UK and Australia.

CHMP Recommends Booster Dose Consideration for Moderna COVID-19 Vaccine

October 29, 2021

EMA’s CHMP concluded that a booster dose of Moderna’s Spikevax vaccine may be considered in people aged 18 and older.

FDA Approves Genentech’s Susvimo for Wet AMD

October 29, 2021

Genentech’s Susvimo (ranibizumab injection) is approved for intravitreal use via ocular implant for the treatment of neovascular age-related macular degeneration.

BD Launches Plunger Stopper in Partnership with Aptar Pharma

October 29, 2021

Becton, Dickinson, and Company and partner Aptar’s new plunger stopper will support the injection of biologics into subcutaneous tissue.

Bio-Rad Launches Real-Time PCR Detection Systems for In-Vitro Diagnostics

October 29, 2021

Bio-Rad will be launching two new real-time PCR detection tools to be used for in-vitro diagnostic testing.

MilliporeSigma’s Millicell DCI Digital Cell Imager Offers Quick, Accurate, and Objective Cell Monitoring

October 29, 2021

MilliporeSigma’s newly launched Millicell DCI Digital Cell Imager quickly and objectively assesses common cell culture parameters and growth trends for more consistent cell cultures.

Otsuka Applies to EMA for Marketing Authorization of Vadadustat

October 29, 2021

Otsuka has submitted an initial marketing authorization application to EMA for vadadustat as a treatment of anemia associated with CKD in adults.

Vertex and Mammoth Enter into Gene-Editing Partnership Worth Up to $691 Million

October 29, 2021

The $691 million deal will see Vertex use Mammoth’s systems to discover and develop in-vivo gene-editing therapies.

ten23 health Acquires swissfillon to Enhance its Integrated Offering

October 29, 2021

Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.